Skip to main content
. 2023 Jan 4;28:101612. doi: 10.1016/j.tranon.2022.101612

Fig. 6.

Fig 6

MiR-384 represses ccRCC cell progression through targeting FN1. (A) The viability of KMRC-1 and KMRC-3 cells transfected with si-FN1, si-NC, inhibitor, inhibitor-NC, or si-FN1 + inhibitor was measured by CCK-8 assay. (B) Apoptosis in these above transfected ccRCC cells 2was determined by the caspase-3 activity assay. (C) The numbers of migratory in these above transfected ccRCC cells were assessed by Transwell assay. *P < 0.05, **P < 0.01 vs. si-NC group; #P < 0.05, ##P < 0.01 vs. inhibitor-NC; &P < 0.05, &&P < 0.01 vs. si-FN1 + inhibitor.